Gamma Knife Market by Disease Indication (Brain Metastasis, Cancer, Arteriovenous Malformation (AVM) and Trigeminal Neuralgia)
The Global revenue from the Gamma Knife Market was around US$ 185.7 Million in 2022, with the global market expected to grow at a CAGR of 4.8% to reach a valuation of around US$ 311.4 Million by the end of 2033.
Radiation therapy is a procedure entailing the precise delivery of high doses of radiation to tumors and other relevant anatomical targets. It involves the usage of sophisticated technology to ablate tumors and other abnormalities with noninvasive procedures and high doses of radiation while minimizing the exposure to surrounding healthy tissues.
Gamma Knife radiosurgery is a major form of radiation therapy. It is mainly used to treat brain tumors, arteriovenous malformations, trigeminal neuralgia, acoustic neuroma, and pituitary tumors. In Gamma Knife surgery, specialized equipment focuses close to 200 tiny beams of radiation on a tumor or other targeted cells. Each beam has minimal effect on the brain tissue and it delivers strong doses of radiation to the targeted tumor cells for treatment.
Click on the link for sample report: https://www.persistencemarketresearch.com/samples/3742
Increasing prevalence of cancer, growing aging population, rising number of initiatives undertaken by various government associations, and advanced features of Gamma Knife systems are major drivers of the global Gamma Knife market. On the other hand, stringent regulatory requirements and prolonged approval time for Gamma Knife systems as well as high cost of implementation and shortage of skilled manpower are some major concerns for the global Gamma Knife market.
In terms of geography, North America dominates the global Gamma Knife market due to increasing prevalence of cancer as well as increasing investments by radiosurgery systems manufacturing companies. In addition, increased awareness about Gamma Knife technology for cancer treatment is also boosting the growth of the Gamma Knife market in the region. The U.S. represents the largest market for Gamma Knife, followed by Canada, in North America. In Europe, Germany, France, the U.K., Italy, and Spain hold major shares of the Gamma Knife market. However, Asia represents the fastest growing region in the Gamma Knife market. This is due to increasing prevalence of cancer and growing aging population. In Latin America, rising incidence of cancer and construction of manufacturing and research facilities by many companies is driving the Gamma Knife market in the region.
This report provides in-depth analysis and estimation of the Gamma Knife market for the period 2014 to 2020, considering 2013 as the base year for calculation. In addition, data pertaining to current market dynamics, including market drivers, restraints, trends, and recent developments, has been provided in the report. The Gamma Knife market is categorized on the basis of application and geography. Based on the application, the Gamma Knife market is further categorized into brain market metastases, brain tumor, trigeminal neuralgia, arteriovenous malformations, and others. On the basis of geography, the Gamma Knife market report identify analyzes the size and predictions for North America, Europe, Asia, Latin America, and Rest of the World (RoW).
Drivers and Restraints:
Drivers:
Restraints:
Key Companies:
Click on the link for customized report: https://www.persistencemarketresearch.com/request-customization/3742
Segmentation:
Disease Indication:
Organ Treated:
Region:
This report covers a thorough analysis of:
Regional analysis includes:
Report highlights:
Click on the link to access the full report: https://www.persistencemarketresearch.com/checkout/3742
Related Reports -
Persistence Market Research’s Expertise in Life Sciences and Transformational Health Our expert team of industry analysts comprising management graduates, medical professionals, engineers, and project managers provides insights on emerging therapy areas,
Gamma Knife , Radiosurgery , Brain Tumor , Neurosurgery , Cancer Treatment , Non-invasive , High Precision , Radiation Therapy , Stereotactic Radiosurgery , Medical Device , Oncology , Brain Metastases
Jun 08, 2023